We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Vital Signs Measurement Can Predict Cardiac Arrest

By HospiMedica International staff writers
Posted on 02 Jun 2011
A new study reveals that that a composite index used by emergency room physicians and response teams to assess the likelihood of a patient dying was a better predictor of cardiac arrest than any single vital sign. More...


Researchers at the University of Chicago (IL, USA) performed a nested case-control study over the course of two years, matching 83 cardiac arrest patients to 332 patients controls divided into four randomly selected controls, who were patients in the same unit at the same time. Among the control patients, approximately 75% were medical admissions, while the rest were surgical. The researchers attempted to validate the Modified Early Warning Score (MEWS) composite index.

The results showed that the case patients were significantly older, were hospitalized longer prior to suffering cardiac arrest, and were more likely to have had a prior rapid response call or intensive care unit (ICU) admission. On admission, the case patients and the controls had similar mean vital signs and MEWS, with two significant exceptions: case patients had lower diastolic blood pressure and higher respiratory rates.

The results showed that mean MEWS was significantly higher in patients who would suffer a cardiac arrest within 48 hours than it was for the study's controls, and the difference increased leading up to the event. Individual vital signs, including maximum respiratory rate, maximum heart rate, maximum pulse pressure, and minimum diastolic blood pressure were also found to be statistically significant predictors of cardiac arrest. MEWS variables that were not statistically significant included temperature, minimum heart rate, and systolic blood pressure. The study was presented at the American Thoracic Society (ATS) international conference, held during May 2011 in Denver (CO, USA).

"Because current activation systems don't utilize the best vital sign predictors, they often suffer from poor sensitivity and high false-positive rates. This limits the effectiveness of the rapid response team, and the high false-positive rates can lead to 'alarm fatigue' and the wasting of hospital resources,” said lead author and study presenter Matthew Churpek, MD, MPH. "The creation of an evidence-based cardiac arrest prediction tool would decrease the false-positive rate and lead to a response system with a better chance of improving patient outcomes.”

Related Links:

University of Chicago






Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.